Sign in
Back
Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis
Journal article   Open access  Peer reviewed

Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis

Emilie Fowler, Jordan Rosen, Hadar Lev-Tov and Gil Yosipovitch
Acta dermato-venereologica, Vol.99(10), pp.899-900
2019-09-01
DOI: https://doi.org/10.2340/00015555-3201
PMID: 31037315

Abstract

Adult Antibodies, Monoclonal, Humanized - therapeutic use Anus Neoplasms - diagnosis Anus Neoplasms - immunology Anus Neoplasms - therapy Carcinoma, Squamous Cell - diagnosis Carcinoma, Squamous Cell - immunology Carcinoma, Squamous Cell - therapy Dermatitis, Atopic - diagnosis Dermatitis, Atopic - drug therapy Dermatitis, Atopic - immunology Dermatologic Agents - therapeutic use Female Humans Immunosuppressive Agents - therapeutic use Male Melanoma - diagnosis Melanoma - immunology Melanoma - therapy Skin Neoplasms - diagnosis Skin Neoplasms - immunology Skin Neoplasms - therapy Treatment Outcome Young Adult
url
https://doi.org/10.2340/00015555-3201View
Published (Version of record) Open

Metrics

141 Record Views
15 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.65 Allergy
1.65.1091 Atopic Dermatitis
Web Of Science research areas
Dermatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details